109: Bioreactor Team

Healthcare providers around the world experience inconsistent plasma supply used for trauma victims and surgery. The limitation of the existing plasma supply system is that it is entirely reliant on donors, who don’t consistently donate plasma, resulting in large fluctuations with long periods of low plasma stocks. This project aims to help mitigate the issue of the inconsistent plasma supply the healthcare system experiences by utilizing bioreactors and modified E. coli to create recombinant human serum albumin.